NCT01635283View on ClinicalTrials.gov

Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 10, 2012

Primary Completion Date

May 13, 2016

Study Completion Date

May 13, 2016

Conditions
Adult Diffuse AstrocytomaAdult Mixed GliomaAdult OligodendrogliomaRecurrent Adult Brain TumorAdult Oligoastrocytoma
Interventions
BIOLOGICAL

tumor lysate-pulsed autologous dendritic cell vaccine

Given ID

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

90095

Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
lead

Jonsson Comprehensive Cancer Center

OTHER

NCT01635283 - Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma | Biotech Hunter | Biotech Hunter